Detalhe da pesquisa
1.
COVID-19 and Mixed Cryoglobulinemia Syndrome: Long-Term Survey Study on the Prevalence and Outcome, Vaccine Safety, and Immunogenicity.
J Clin Immunol
; 43(4): 680-691, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36795264
2.
Serological and Molecular Characterization of Hepatitis C Virus-Related Cryoglobulinemic Vasculitis in Patients without Cryoprecipitate.
Int J Mol Sci
; 24(14)2023 Jul 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37511357
3.
Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases.
J Autoimmun
; 131: 102866, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35841684
4.
Hematological and Genetic Markers in the Rational Approach to Patients With HCV Sustained Virological Response With or Without Persisting Cryoglobulinemic Vasculitis.
Hepatology
; 74(3): 1164-1173, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33721342
5.
B-cell activating factor (BAFF), BAFF promoter and BAFF receptor allelic variants in hepatitis C virus related Cryoglobulinemic Vasculitis and Non-Hodgkin's Lymphoma.
Hematol Oncol
; 40(4): 658-666, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35460540
6.
Solving the mystery of HBV-related mixed cryoglobulinemia: potential biomarkers of disease progression.
Rheumatology (Oxford)
; 60(9): 4418-4427, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33590837
7.
Flares of mixed cryoglobulinaemia vasculitis after vaccination against SARS-CoV-2.
Ann Rheum Dis
; 81(3): 441-443, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34819272
9.
Evaluation of Plasma miR-17-5p, miR-24-3p and miRNA-223-3p Profile of Hepatitis C Virus-Infected Patients after Treatment with Direct-Acting Antivirals.
J Pers Med
; 13(8)2023 Jul 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37623439
10.
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase.
J Transl Autoimmun
; 7: 100212, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37854035
11.
Predictors of long-term cryoglobulinemic vasculitis outcomes after HCV eradication with direct-acting antivirals in the real-life.
Autoimmun Rev
; 21(1): 102923, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34419670
12.
Rapid improvement of psychiatric stigmata after IFN-free treatment in HCV patients with and without cryoglobulinemic vasculitis.
Clin Rheumatol
; 41(1): 147-157, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34409558
13.
COVID-19 vaccine immunogenicity in 16 patients with autoimmune systemic diseases. Lack of both humoral and cellular response to booster dose and ongoing disease modifying therapies.
J Transl Autoimmun
; 5: 100164, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36120415
14.
The Relevance of MicroRNAs in the Pathogenesis and Prognosis of HCV-Disease: The Emergent Role of miR-17-92 in Cryoglobulinemic Vasculitis.
Viruses
; 12(12)2020 11 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33260407
15.
Role of Notch Receptors in Hematologic Malignancies.
Cells
; 10(1)2020 12 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33374160
16.
Sentinel biomarkers in HCV positive patients with mixed cryoglobulinemia.
J Immunol Methods
; 476: 112687, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31669506
17.
The metabolic fingerprints of HCV and HBV infections studied by Nuclear Magnetic Resonance Spectroscopy.
Sci Rep
; 9(1): 4128, 2019 03 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30858406
18.
Notch4 and mhc class II polymorphisms are associated with hcv-related benign and malignant lymphoproliferative diseases.
Oncotarget
; 8(42): 71528-71535, 2017 Sep 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29069725
19.
Editorial: interferon-free DAAs are a great boon for patients with hepatitis C and cryoglobulinaemia-Authors' reply.
Aliment Pharmacol Ther
; 48(7): 772-773, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30246308